TRVN:OTCMKTS
Trevena Inc
US$ ०.०६६
०.००%
(०.००) 1D
अक्टोबर १२, १४:५७:२६ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TRVN...
Mkt. cap
५७.०१ हजार
Avg. vol.
२१०.००
Volume
९.००
52-wk high
US$ १.५०
52-wk low
US$ ०.००
Beta
१.०७
Shares outstanding
८.६४ लाख
No. of employees
२३
Mkt. cap
५७.०१ हजार
Avg. vol.
२१०.००
Volume
९.००
52-wk high
US$ १.५०
52-wk low
US$ ०.००
Beta
१.०७
Shares outstanding
८.६४ लाख
No. of employees
२३
News stories
From web sources and news partners
Altcoin Buzz
·
५८ मिनेट पहिले
Garlinghouse Rings Nasdaq Bell as Evernorth Deploys 473M XRP
Fierce Biotech
·
१ घण्टा पहिले
City goes public with $200M IPO, while Frazier Life Sciences takes biotech-focused SPAC to Nasdaq
Simply Wall Street
·
४ मिनेट पहिले
Pega Stock Gets Analyst Backing Ahead Of Results
Yahoo Finance
·
२९ मिनेट पहिले
US Stock Market Today: S&P 500 Futures Ease As Hot Core CPI Hits Rate Hopes
Profile
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz winner of the 2012 Nobel Prize in Chemistry and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Trevena's expertise lies in engineering "biased ligands" that activate only the beneficial signaling pathways downstream of a GPCR to unlock new biology and avoid drug adverse effects. Trevena's pipeline currently includes a clinical stage mu-opioid biased ligand for post-operative pain, and discovery-stage programs for chronic pain, migraine, and Parkinson's disease. Wikipedia
About Trevena Inc
CEO-
Employees२३
Founded२००७
Headquartersएट्लान्टा, जर्जिया, संयुक्त राज्य अमेरिका
Sector-
Websitetrevena.com